ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $21,410,000 | – | 500,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 4,087,521 | $111,426,000 | 82.89% |
Wildcat Capital Management, LLC | 906,194 | $24,698,000 | 10.49% |
TPG Group Holdings (SBS) Advisors, Inc. | 42,432,612 | $1,156,500,000 | 8.54% |
Coastal Bridge Advisors, LLC | 824,617 | $22,475,000 | 7.68% |
BAINCO INTERNATIONAL INVESTORS | 355,913 | $9,700,000 | 1.50% |
Avoro Capital Advisors LLC | 1,128,594 | $30,760,000 | 1.28% |
Perceptive Advisors | 1,543,790 | $42,075,000 | 1.13% |
Capital Impact Advisors, LLC | 75,418 | $2,055,000 | 0.78% |
DSAM Partners (London) Ltd | 107,441 | $2,928,000 | 0.55% |
SHIKIAR ASSET MANAGEMENT INC | 34,995 | $954,000 | 0.38% |